Healthy adults were tracked before, during and after high doses of psilocybin and methylphenidate to assess how psychedelics can change human brain networks, and psilocybin was found to massively disrupt functional connectivity in cortex and subcortex with some changes persisting for weeks.
A new treatment has been shown to effectively combat cognitive decline in mice with Alzheimer's disease. Alzheimer's disease, a progressive neurodegenerative disorder, stands as the primary cause of dementia. This condition leads to cognitive deterioration, memory loss, and eventually renders indiv